Increasing Rates of Real-World Studies in EGFR-Mutated NSCLC
November 24th 2021Drs Lyudmila Bazhenova and Federico Albrecht comment on the significance of real-world data collection in EGFR-mutated non–small cell lung cancer and suggest what can be done to increase the rates of real-world studies conducted.